Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Thomas Huby"'
Autor:
Thomas Huby, Edouard Le Guillou, Cyril Burin des Roziers, Laurence Pacot, Audrey Briand-Suleau, Albain Chansavang, Aurélie Toussaint, Véronique Duchossoy, Nicolas Vaucouleur, Virginie Benoit, Laurence Lodé, Clémence Molac, Marie-Odile North, Sarah Grotto, Vassilis Tsatsaris, Anne Jouinot, Béatrix Cochand-Priollet, Anne-Cécile Paepegaey, Juliette Nectoux, Lionel Groussin, Eric Pasmant
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 107:e1367-e1373
Context Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disease caused by mutations in the tumor suppressor gene MEN1. The uncertainty of pathogenicity of MEN1 variants complexifies the selection of the patients likely to benefit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09899c1e5c14d5ce5eb7f3e051b5e4c3
https://doi.org/10.1210/clinem/dgab894
https://doi.org/10.1210/clinem/dgab894
Autor:
Kenneth Chappell, Bruno Francou, Christophe Habib, Thomas Huby, Marco Leoni, Aurélien Cottin, Florian Nadal, Eric Adnet, Eric Paoli, Christophe Oliveira, Céline Verstuyft, Anne Davit-Spraul, Pauline Gaignard, Elise Lebigot, Jean-Charles Duclos-Vallee, Jacques Young, Peter Kamenicky, David Adams, Andoni Echaniz-Laguna, Emmanuel Gonzales, Claire Bouvattier, Agnes Linglart, Véronique Picard, Emilie Bergoin, Emmanuel Jacquemin, Anne Guiochon-Mantel, Alexis Proust, Jérôme Bouligand
Publikováno v:
Clinical Chemistry. 68:313-321
BackgroundTo date, the usage of Galaxy, an open-source bioinformatics platform, has been reported primarily in research. We report 5 years’ experience (2015 to 2020) with Galaxy in our hospital, as part of the “Assistance Publique–Hôpitaux de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0024a3677681b9863a79bb47a02f93f7
https://doi.org/10.1093/clinchem/hvab220
https://doi.org/10.1093/clinchem/hvab220
Autor:
Wilfried Le Goff, Raphaëlle Ballaire, Fulvia Troise, Martine Moreau, Lucie Poupel, Philippe Lesnik, Francesco Potì, Thomas Huby, Emanuele Sasso, Emmanuel L. Gautier, Thierry Huby, Lauriane Galle-Treger
Publikováno v:
Cardiovascular Research
Cardiovascular Research, Oxford University Press (OUP), 2020, 116 (3), pp.554-565. ⟨10.1093/cvr/cvz138⟩
Cardiovascular Research, Oxford University Press (OUP), 2020, 116 (3), pp.554-565. ⟨10.1093/cvr/cvz138⟩
Aims SR-B1 is a cholesterol transporter that exerts anti-atherogenic properties in liver and peripheral tissues in mice. Bone marrow (BM) transfer studies suggested an atheroprotective role in cells of haematopoietic origin. Here, we addressed the sp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b27b15deff4f672b2f746155d9a53a6
https://hal.sorbonne-universite.fr/hal-02967904
https://hal.sorbonne-universite.fr/hal-02967904
